ShowcasesPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.

WAKAMOTO PHARMACEUTICAL CO.,LTD.JP:4512

Market cap
¥8.6B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2013		Mar 31,
2014		Mar 31,
2015		Mar 31,
2016		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023
Net sales of finished goods8,902----------
Net sales of goods1,017----------
Leasing business revenue8----------
Net sales1,828----------
Beginning finished goods and goods1,410----------
Cost of products manufactured3,917----------
Cost of purchased goods723----------
Cost of sales in leasing business9----------
Total-26,060----------
Transfer to other account68----------
Ending finished goods and goods1,375----------
Cost of sales4,617----------
Gross profit (loss)5,310----------
Selling, general and administrative expenses5,286----------
Operating profit (loss)21----------
Interest income1----------
Dividend income35----------
Other77----------
Non-operating income268----------
Interest expenses27----------
Donations34----------
Loss on retirement of non-current assets1----------
Other34----------
Non-operating expenses110----------
Ordinary profit (loss)180----------
Extraordinary income481----------
Loss on retirement of non-current assets54----------
Extraordinary losses212----------
Profit (loss) before income taxes449----------
Income taxes - current47----------
Income taxes - deferred218----------
Income taxes265----------